The Global Cardiac Pacemaker Market size is expected to register a CAGR of 6.2% during the forecast period 2021-2028 and to reach USD 36,617 million by 2028. The major drivers for this growth are the increasing prevalence of heart diseases, the rising geriatric population with associated cardiovascular disorders, and technological advancements in implantable cardiac pacemakers from emerging economies such as India and China.
Cardiac Pacemaker is a device that is implanted in the chest cavity, and it regulates the heart's rhythm. A healthy human body has an electrical system that sends messages throughout our bodies to make them function properly. The cardiac pacemaker was invented by Wilson Greatbatch who wanted to help people suffering from irregular heartbeats or someone with a damaged heart (heart attack). The main purpose of this device is not only for regulating the heartbeat - but also for treating different types of arrhythmias such as atrial fibrillation [irregular heartbeat], etc.
Pacemakers are used during treatment for congestive heart failure, high blood pressure, and coronary artery disease; they can be set up so that when one chamber becomes irritable, its pacing activity will override other chambers and thus pacemaker will keep the heart pumping in an orderly manner.
On the basis of Type, the market is segmented into Implantable Cardiac Pacemaker and External Cardiac Pacemaker. Implantable heart pacemakers are segment expected to register higher growth rates over external cardiac pacemakers owing to increasing adoption for major procedures such as transcatheter aortic valve replacement (TAVR) procedure.
An implantable Cardiac Pacemaker is a device implanted in the body with electrodes that are connected to either wall of the heart, by transmitting electrical signals through an electrode wire. The Implantable Cardiac Pacemaker is placed under the skin on top of the chest muscle; it is then positioned near the left or right ventricle to stimulate contractions and regulate heartbeat.
Implantable Cardiac Pacemakers are used to treat various cardiac arrhythmias. It can either be an atrial or ventricular implant and is positioned near the left or right ventricle in order to stimulate contractions and regulate heartbeat. It also regulates heartbeat which in turn helps prevent fatal cardiac events like arrhythmia. The Implantable Cardiac Pacemaker helps prevent fatal cardiac events like arrhythmia that would result from bradyarrhythmias, tachycardia, congestive heart failure (CHF), among other conditions.
External Cardiac Pacemaker is an electronic device that is implanted to the outside of a person’s chest. This pacemaker is used in those with electrical problems who need extra stimulation to keep their heart beating at a regular pace. External Cardiac Pacemakers are also known as external cardiac pacing devices and they work by sending pulses from the pulse generator in order to maintain or restore the automaticity of one's heartbeat.
These devices work by sending pulses from the pulse generator, which may consist of an internal or external pacemaker device that sends impulses to stimulate contractions of the heart when needed. They often include leads that are attached directly onto one's heart muscle through small incisions on their chest wall or abdomen as well as electrodes placed anywhere on your body where you want it stimulated such as your back, neck, or arms.
They are used in those with electrical problems who need extra stimulation to keep their heart beating at a regular pace. In the majority of cases, External Cardiac Pacing is not permanent and can be discontinued once certain conditions have been corrected.
On the basis of Application, the market is segmented into Hospitals, Cardiac Centers, and Ambulatory Surgical Centers. In the North American region, hospitals accounted for a significant share in total revenue generated by External cardiac devices in 2018 owing to its increasing prevalence among patients suffering from cardiovascular diseases such as hypertension or heart failure.
On the basis of Region, the market is segmented into North America, Europe, Asia Pacific, and Middle East & Africa. The North American market is expected to grow significantly during the forecast period. A rise in the geriatric population base and increasing awareness among people regarding pacemaker usage will drive market growth in the North American region. Cardiac centers are majorly adopting external cardiac pacemakers for patients with severe heart disease or advanced stages of cardiomyopathy, etc., which is also driving the demand for cardiac devices on an average worldwide level.
North America is currently dominating all other regions while the Asia Pacific region has grown steadily due to large population size and increased awareness among people regarding cardiometabolic diseases which will lead to this region's demand for cardiovascular technologies in coming years.
The European market is expected to grow owing to the presence of well-established healthcare systems across countries along with improving distribution channels has increased adoption rates over time, which would result in anticipated high growths in this region over the coming years. Germany is one country that dominates the global cardiovascular device market, with an estimated share of 18% in 2018.
Up Market Research published a new report titled “Cardiac Pacemaker Market research report which is segmented by Types (Implantable Cardiac Pacemake, External Cardiac Pacemaker), By Applications (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), By Players/Companies Medtronicâ€™S, St.Jude Medical, Boston Scientific, BIOTRONIK, Lepu Medical Technology, MEDICOWEB, Pacetronix, LivaNova, Osypka Medical”.
|Report Attributes||Report Details|
|Report Title||Cardiac Pacemaker Market Research Report|
|By Type||Implantable Cardiac Pacemake, External Cardiac Pacemaker|
|By Application||Hospitals, Cardiac Centers, Ambulatory Surgical Centers|
|By Companies||Medtronicâ€™S, St.Jude Medical, Boston Scientific, BIOTRONIK, Lepu Medical Technology, MEDICOWEB, Pacetronix, LivaNova, Osypka Medical|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||236|
|Number of Tables & Figures||166|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Implantable Cardiac Pacemake, External Cardiac Pacemaker and By Application Hospitals, Cardiac Centers, Ambulatory Surgical Centers.
Some of the companies that are profiled in this report are:
Cardiac Pacemaker Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Cardiac Pacemaker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Cardiac Pacemaker Market Report:
Some other reports from this category!